Cohort B 28 days:
OR was 86% (or 6/7 patients)
CR was 57% (or 4/7 patients)
Highlight:
The higher dose achieved a CR in 57% (4/7) of patients after only 28 days, while the lower dose had resulted in 12.5% (1/8) at that mark (50% after 100 days).
Meaning:
The CR is likely to increase even more on day 100.
Ann: Positive 28-day Clinical Trial Data in Cohort B, page-5
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28606 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 35000 | 1 |
View Market Depth
| Last trade - 10.21am 14/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable